Stock Detail
PSYCHEMEDICS CORPORATION
Sector: Health Services
Latest Quote @ Mon May 5 02:53:09 (15 min delayed)
| N/A |
N/A |
$11.26 |
-0.01 |
-0.09% |
|
Last Day's Data
| $11.26 |
$11.32 |
$0.00 |
0.00% |
0.60 |
$11.27 |
| $11.23 |
$11.20 |
5,061.00 |
59.37M |
9,968.00 |
19.97 |
Pivot Table
| R2 |
R1 |
Pivot |
S1 |
S2 |
| 11.38 |
11.32 |
11.26 |
11.20 |
11.14 |
Stock Profile
Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Its testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry. The company offers commercial testing and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, PCP, methamphetamine, and opiates. Psychemedics' tests provides quantitative information, which indicates the approximate amount of drug ingested, as well as historical data, which can show a pattern of individual drug use over a period of time. Its information is useful to employers, physicians, treatment professionals, law enforcement agencies, schools, and parents concerned about drug use by their children, as well as other individuals and entities. The company also offers PDT-90, a personal drug testing service for parents concerned about drug use by their children. Psychemedics markets its corporate drug testing services through own sales force; and PDT-90 through the Internet and retail distributors in the United States. The company was founded in 1985 and is based in Acton, Massachusetts.
